Fiche société
Matthew Bucknor
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)This study is a single site, single-arm, feasibility study to evaluate the safety and efficacy of MRgFUS using the ExAblate 2100 System for the partial ablation of undifferentiated pleomorphic sarcomas. | Cancer | Non applicable | À vérifier | United States | À vérifier |
| ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)This study is a single site, single-arm, feasibility study to evaluate the safety and efficacy of MRgFUS using the ExAblate 2100 System for the partial ablation of undifferentiated pleomorphic sarcomas. | Cancer | Non applicable | United States | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS) | Cancer | Non applicable | NCT04123535 | HIFU-UPS — Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic Sarcoma | TERMINATED |
Publications
0| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Aucune publication. | ||||